| 000 | 01018 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250513190614.0 | ||
| 264 | 0 | _c19991005 | |
| 008 | 199910s 0 0 jpn d | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNakayama, K | |
| 245 | 0 | 0 |
_a[Toxic and adverse neurologic effects of neuroleptics]. _h[electronic resource] |
| 260 |
_bRyoikibetsu shokogun shirizu _c1999 |
||
| 300 |
_a532-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntidepressive Agents _xadverse effects |
| 650 | 0 | 4 |
_aAntidepressive Agents, Tricyclic _xadverse effects |
| 650 | 0 | 4 |
_aAntipsychotic Agents _xadverse effects |
| 650 | 0 | 4 | _aButyrophenones |
| 650 | 0 | 4 | _aDiagnosis, Differential |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLithium Carbonate _xadverse effects |
| 650 | 0 | 4 |
_aNeuroleptic Malignant Syndrome _xdiagnosis |
| 650 | 0 | 4 | _aPhenothiazines |
| 650 | 0 | 4 | _aPrognosis |
| 700 | 1 | _aYakutsu, N | |
| 700 | 1 | _aKoga, M | |
| 773 | 0 |
_tRyoikibetsu shokogun shirizu _gno. 27 Pt 2 _gp. 532-7 |
|
| 999 |
_c10392488 _d10392488 |
||